Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke

Post time 1 hour(s) ago

journal：Journal of Clinical Neuroscience

Authors：Francisco Hernández-Bernal; Nelvys Subirós-Martínez; Juan H. Gutiérrez-Ronquillo; Elizabeth Colina-vila; Marbelys Guevara-Rodríguez; Donner Estenoz-García; Karem Catasús-lvarez; Yenima Martín-Bauta; Héctor Pérez-Saad; Ana M. Manso-López; Alejandro Batista-Izquierdo; Evelio González-Dalmau; Taimy Amador-Nuez; Verena L. Muzio-González; Gerardo E. Guillén-Nieto; Diana Garcia-del-Barco-Herrera

Published date：2026-10-

DOI：10.1016/j.jocn.2026.112195

PDF link：https://www.sciencedirect.com/sc ... 967586826003462/pdf

Article link：https://doi.org/10.1016/j.jocn.2026.112195

Article Source：Elsevier BV。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke